cerrar
Tagged with EU

Can Europe’s Beating Cancer Plan Make it an Innovation…
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in Europe, and its potential to boost the…

Michael Sidler – Co-Founding Partner, Redalpine Venture…
Redalpine Venture Partners' Dr Michael Sidler highlights some of the key trends in the European biotech VC space, the funding and operational…

Ichnos CEO on Glenmark Legacy, Biotech Transformation &…
After an illustrious career in oncology R&D, contributing greatly to the development of cutting-edge cancer therapies at Novartis and Gilead,…

Jazz’s $7.2 Billion GW Pharma Deal: A Major Boost for…
The first day of March 2013 also marked a first for GW Pharmaceuticals. On that day, the British biopharmaceutical company successfully listed on…

Swiss Pharma: Staying the Course
This article forms part of Healthcare & Life Sciences Review: Switzerland February 2021, a comprehensive up-to-date country report on the Swiss…

Brian O’Callaghan – CEO, ObsEva
Biotech veteran Brian O’Callaghan introduces ObsEva – a Swiss-based firm focused on women’s health –, his motivations to join the company –…

Latvia: Striving to Catch Up to its Neighbours on Innovation…
Dr Valters Bolevics, director general of the Association of International Research-based Pharmaceuticals Manufacturers of Latvia (SIFFA), outlines the…

Europe: EMA Medicine Approvals 2020
The full list of medicines recommended for approval by the European Medicines Agency (EMA) in 2020 divided by therapeutic area and with drugs that…

Nicolas Fischer – CEO, Light Chain Bioscience
Dr Nicolas Fischer introduces Light Chain Bioscience, a Swiss biotech company focusing on the discovery and development of bispecific antibodies using…

Alessandro Riva – CEO, Ichnos Sciences
Alessandro Riva, MD joined biotech Ichnos Sciences as its founding CEO in 2019, leaving behind a storied career in oncology R&D at Novartis and…

STADA’s Bold Bets on M&A
After a year of growth and acquisitions, 125-year-old German generics manufacturer STADA is showing a willingness to make bold bets on areas including…

After Brexit: Focus on the New Pharmaceutical Strategy for Europe
Writing in the February edition of DIA’s Global Forum magazine, Thomas Kühler of Sanofi R&D looks at the future of European pharma post-Brexit,…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here